Latest action: Read twice and referred to the Committee on Finance.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Excludes clinical trial participant income from taxation.
The problem
People who earn money participating in medical research studies may face tax burdens on this income, potentially discouraging participation in important clinical trials.
The proposal
The bill exempts income earned by participants in clinical trials from federal income tax, allowing them to keep trial compensation without tax liability.
The impact
Clinical trial participants would pay no federal income tax on trial earnings. This affects medical research participation rates and reduces federal tax revenue from this income source.
Removing the tax burden makes clinical trials more attractive to potential participants. This could increase enrollment in trials, accelerating medical research and drug development. More participants means faster answers to health questions.
People with limited income often need money and rely on trial compensation. Eliminating taxes on this income provides meaningful financial relief. This reduces barriers for those who need money most.
Excluding trial income reduces complexity for participants and the IRS. People don't need to report this income or calculate related taxes. This saves time and reduces administrative burden.
Clinical trials are essential for developing new treatments and medicines. Higher participation rates mean better research outcomes. Society benefits from faster medical breakthroughs.
The government collects less income tax when trial participant earnings are exempt. This creates a revenue loss that must be addressed elsewhere. Federal budgets could be negatively impacted.
Higher-income people can participate in trials and receive tax-free compensation. Wealthier individuals benefit proportionally more from this tax break. This could be seen as unfairly favoring the wealthy.
The bill lacks detail about what qualifies as a clinical trial or participant. This ambiguity could lead to disputes over eligibility and implementation. Businesses might abuse loopholes without clear guidelines.
Without strict definitions, people might claim non-trial income as trial-related earnings. Companies could structure payments to look like trial compensation. The tax code could be manipulated through creative interpretations.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Other bills in this policy area
HR 10730
Healthy Communities Act of 2026
HR 5349
TAS Act
HR 9496
End Tax Penalties on American Hostages Act
HR 997
National Taxpayer Advocate Enhancement Act of 2025
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.